BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26915706)

  • 1. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
    Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
    Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
    Lommatzsch PK; Werschnik C; Schuster E
    Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanomas. Conservation treatment.
    Munzenrider JE
    Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of proton radiotherapy for uveal melanomas.
    Egger E; Zografos L; Munkel G; Böhringer T; Bercher L; Chamot L
    Front Radiat Ther Oncol; 1997; 30():111-22. PubMed ID: 9205891
    [No Abstract]   [Full Text] [Related]  

  • 17. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.
    Thariat J; Grange JD; Mosci C; Rosier L; Maschi C; Lanza F; Nguyen AM; Jaspart F; Bacin F; Bonnin N; Gaucher D; Sauerwein W; Angellier G; Hérault J; Caujolle JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):328-335. PubMed ID: 27084650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
    Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.